59
Participants
Start Date
September 16, 2019
Primary Completion Date
May 3, 2021
Study Completion Date
May 3, 2021
ALA-1000
Blood sample for PK analysis are collected before and post single injection of ALA-1000 (Day1) according to the schedule of procedures. Subjects remain in the residential phase through Day21 for safety assessment.
buprenorphine sublingual film
ALA-1000 injection after 7 days of buprenorphine sublingual film dosing. Blood sample for PK analysis are collected before and post sublingual buprenorphine dosing on Day-1
Innovative Clinical Research, Miami
Lead Sponsor
Alar Pharmaceuticals Inc.
INDUSTRY